Certolizumab pegol Not Yet Recruiting Phase 4 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02597829Does Clinical Response Correlate With Serum Certolizumab Levels?